AlphaQuest LLC Raises Stock Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

AlphaQuest LLC boosted its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 255.5% during the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 871 shares of the biotechnology company’s stock after buying an additional 626 shares during the period. AlphaQuest LLC’s holdings in Axon Enterprise were worth $518,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Public Sector Pension Investment Board raised its holdings in Axon Enterprise by 19.2% during the 3rd quarter. Public Sector Pension Investment Board now owns 3,104 shares of the biotechnology company’s stock valued at $1,240,000 after buying an additional 500 shares during the period. CIBC Asset Management Inc raised its holdings in Axon Enterprise by 9.2% during the 3rd quarter. CIBC Asset Management Inc now owns 10,578 shares of the biotechnology company’s stock valued at $4,227,000 after buying an additional 895 shares during the period. Axxcess Wealth Management LLC purchased a new stake in Axon Enterprise during the 3rd quarter valued at $814,000. Soros Capital Management LLC purchased a new stake in Axon Enterprise during the 3rd quarter valued at $630,000. Finally, Friedenthal Financial raised its holdings in Axon Enterprise by 961.7% during the 4th quarter. Friedenthal Financial now owns 1,359 shares of the biotechnology company’s stock valued at $808,000 after buying an additional 1,231 shares during the period. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Axon Enterprise Price Performance

Shares of AXON stock opened at $557.89 on Thursday. Axon Enterprise, Inc. has a 1-year low of $273.52 and a 1-year high of $715.99. The stock’s 50-day moving average is $595.56 and its 200 day moving average is $532.90. The company has a market cap of $42.75 billion, a P/E ratio of 144.16, a PEG ratio of 5.17 and a beta of 1.12. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63.

Insider Activity at Axon Enterprise

In related news, President Joshua Isner sold 1,291 shares of the firm’s stock in a transaction dated Tuesday, December 17th. The stock was sold at an average price of $642.43, for a total transaction of $829,377.13. Following the sale, the president now owns 181,892 shares of the company’s stock, valued at $116,852,877.56. This trade represents a 0.70 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total value of $271,831.50. Following the completion of the sale, the director now owns 6,929 shares of the company’s stock, valued at approximately $4,185,601.03. This trade represents a 6.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 5,146 shares of company stock valued at $3,262,847 over the last quarter. 6.10% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

Several analysts recently weighed in on the company. The Goldman Sachs Group increased their price target on Axon Enterprise from $500.00 to $700.00 and gave the company a “buy” rating in a report on Monday, January 27th. Morgan Stanley upgraded Axon Enterprise from an “equal weight” rating to an “overweight” rating and increased their target price for the stock from $500.00 to $700.00 in a research note on Tuesday, December 3rd. TD Cowen assumed coverage on Axon Enterprise in a research note on Wednesday, January 8th. They issued a “buy” rating and a $700.00 target price on the stock. Barclays reiterated a “hold” rating on shares of Axon Enterprise in a research note on Monday. Finally, Craig Hallum lowered Axon Enterprise from a “buy” rating to a “cautious” rating in a research note on Monday. One analyst has rated the stock with a sell rating, three have given a hold rating and twelve have assigned a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $587.38.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.